{"id":"NCT05569148","sponsor":"Hoffmann-La Roche","briefTitle":"A Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the Faricimab Prefilled Syringe","officialTitle":"A Phase IIIb, Open-Label, Single-Arm Study in Patients With Neovascular Age-Related Macular Degeneration or Diabetic Macular Edema to Evaluate the Safety of the 6-mg Faricimab Prefilled Syringe","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-10-17","primaryCompletion":"2022-11-10","completion":"2022-11-10","firstPosted":"2022-10-06","resultsPosted":"2023-10-10","lastUpdate":"2023-10-10"},"enrollment":35,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Neovascular Age-related Macular Degeneration","Diabetic Macular Edema"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"Faricimab PFS Configuration","otherNames":["VABYSMOâ„¢","RO6867461","RG7716"]}],"arms":[{"label":"Faricimab PFS Configuration","type":"EXPERIMENTAL"}],"summary":"This Phase IIIb, single-arm, open-label multicenter clinical in-use study in patients with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) is designed to assess the ability of the intended users, healthcare providers (HCPs), to follow the Instructions for Use to perform an intravitreal (IVT) injection using the 6-milligram (mg) faricimab prefilled syringe (PFS) configuration per the intended use. Any adverse events occurring during the 7-day study reporting period will be summarized.","primaryOutcome":{"measure":"Percentage of Injection Procedures With Successful Completions on Critical Tasks Performed by Healthcare Providers in the Use of the Faricimab Prefilled Syringe Configuration","timeFrame":"Day 1","effectByArm":[{"arm":"Faricimab PFS Configuration","deltaMin":100,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":3,"countries":["United States"]},"refs":{"pmids":["39931677"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":["Eye irritation"]}}